Stay updated on ENLIVEN Trial Assessing BIO89-100 in NASH
Sign up to get notified when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.

Latest updates to the ENLIVEN Trial Assessing BIO89-100 in NASH page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed; this is a metadata/page-version update and does not change study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoChange DetectedResults have been posted with detailed primary and secondary NASH outcomes and Week 24 endpoints; the eligibility criterion for history of cirrhosis has been removed.SummaryDifference3%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page displays 'Results Submitted' and an expanded list of locations across numerous states, with Revision: v3.3.3.SummaryDifference2%

- Check54 days agoChange DetectedAdded clarification that PubMed-based publications may not all pertain to the study and updated the page revision to v3.3.2. Removed the previous wording tying publications to PubMed via the NCT number and the old revision note v3.2.0.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoval of a government funding/operating status notice from the page. This does not affect the study details, eligibility criteria, locations, or outcomes presented.SummaryDifference0.2%

- Check83 days agoChange DetectedNo significant changes detected in core study details; only minor metadata updates are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ENLIVEN Trial Assessing BIO89-100 in NASH
Enter your email address, and we'll notify you when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.